Hadassah

Abandoned Baby Receives Life-Saving Heart Surgery at Hadassah

Monday, Dec 9 2013

When "Rami," just a few days old, was found in a box on a street in Bethlehem, someone brought him to the Bethlehem Creche, a nearby orphanage. Born with a serious heart problem, he was referred to Hadassah Hospital-Ein Kerem for life-saving surgery and now is recovering in the Pediatric Intensive Care Unit (PICU).

The nuns at the Creche first brought the baby to Bethlehem's Caritas Baby Hospital, where physicians diagnosed a coarctation of the aorta (a narrowing of the major blood vessel that carries blood from the heart to the body). Without corrective surgery, they knew he would die.

"I received a call from the cardiologist and we said we'd find space for him as soon as possible," relates Hadassah Pediatric Cardiothoracic Surgeon Dr. Eldad Erez. "In a newborn, the heart is the size of his fist," he explains. "We plan out the surgery ahead of time and try to be as precise as possible."

Dr. Erez reports that, following this successful surgery, Rami's prognosis is excellent. He adds: "I'm a father of four and, as a dad, I feel particularly happy that a child who has started his life with the double obstacles of abandonment and a congenital heart defect will have a chance at a normal life."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›
alt_text

Friday, Aug 2 2019

Eloxx Pharmaceuticals Announces New Drug Application for Clinical Trial in Cystic Fibrosis Patients

Professor Eitan Kerem, head of the Division of Pediatrics at the Hadassah Medical Organization, will serve as the Global Lead Investigator for this clinical trial.

READ MORE ›
alt_text

Wednesday, Jul 31 2019

Skin Cancer Treatment Enhanced in New Center for Dermatologic Surgery

Thanks to a donation by the Israeli businessman and philanthropist Morris Kahn, a major supporter of the Israeli moon spacecraft “Beresheet,” Hadassah Hospital Ein Kerem has just opened the new Center for Dermatologic Surgery, which offers Mohs surgery for patients with common types of skin cancer.

READ MORE ›
SUPPORT HADASSAH HOSPITALS

Learn more about the Hadassah Medical Organization.

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More